Prelude Therapeutics
D

PRLD

3.59500
USD
0.04
(1.13%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
5,218
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
286,893,529

العنوان: Prelude Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approachesto clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novelpayloads.

أسئلة شائعة حول سهم Prelude Therapeutics